Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0016053 (
fibromyalgia
)
4,687
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several existing techniques for diagnosing
psychiatric illness
in the presence of physical complaints are faulty.
Psychiatric illness
may affect only as few as 30% of patients with
fibromyalgia
in some series. Selection bias overemphasizes the contribution of
psychiatric illness
to fibromyalgic. Much of that illness will be secondary to pain and disability. Some
fibromyalgia
disturbances can arise through insomnia and anxiety. Principles in the classification of
fibromyalgia
are discussed.
...
PMID:Physical and psychological considerations in the classification of fibromyalgia. 269 86
Psychiatric diagnoses, self-reports of symptoms, and illness behavior of 20
fibromyalgia
patients and 23 rheumatoid arthritis patients were compared. The
fibromyalgia
patients were not significantly more likely than the arthritis patients to report depressive symptoms or to receive a lifetime psychiatric diagnosis of major depression. These results do not support the contention that
fibromyalgia
is a form of somatized depression.
Fibromyalgia
patients, however, reported significantly more somatic symptoms of obscure origin and exhibited a pattern of reporting more somatic symptoms, multiple surgical procedures, and help seeking that may reflect a process of somatization rather than a discrete
psychiatric disorder
.
...
PMID:Somatization and depression in fibromyalgia syndrome. 316 84
Twenty-two patients with
fibrositis
and 22 control patients selected from a general medical outpatient population were given 3 standardized psychological questionnaires: the Beck Depression Inventory, the Spielberger State and Trait Anxiety Inventory, and the SCL-90-R. There were no statistically significant differences between
fibrositis
patients and control patients on any of these tests, a finding at variance with a commonly held belief that patients with
fibrositis
have an underlying
psychological disorder
. While psychological factors may be important in some patients with
fibrositis
, these results indicate that the presence of a psychopathologic condition is not mandatory for the persistence of
fibrositis
.
...
PMID:Clinical characteristics of fibrositis. II. A "blinded," controlled study using standard psychological tests. 388 93
No major pathophysiologic or therapeutic findings have appeared over the past year regarding
fibromyalgia
, chronic fatigue syndrome, and myofascial pain syndrome, three poorly understood, controversial, and overlapping syndromes. The frequent prevalence of these disorders in association with Lyme disease and other medical and
psychiatric illness
was emphasized. New studies demonstrated the potential role for central nervous system activation in
fibromyalgia
and chronic fatigue syndrome.
...
PMID:Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. 802 71
Fibromyalgia syndrome
(
FMS
) is characterised by generalised aches, pains, tender points, stiffness and fatigue, yet, despite increasing recognition of this syndrome as a clinical entity, its aetiology remains obscure. There is now increasing evidence that
FMS
represents a distinct rheumatic disorder and should not be regarded as a somatic illness secondary to
psychiatric disorder
.
...
PMID:Fibromyalgia syndrome and psychiatric disorder. 852 24
Polysomnographic findings were compared between a group of patients with the chronic fatigue syndrome (CFS; n = 49) and a matched healthy control (HC) group (n = 20). Sleep initiation and sleep maintenance disturbances were observed in the CFS group. The percentage of stage 4 was significantly lower in the CFS group. A discriminant analysis allowed a high level of correct classification of CFS subjects and HC. Sleep-onset latency and the number of stage shifts/hour contributed significantly to the discriminant function. The presence of these anomalies as well as the decrease in stage 4 sleep were not limited to the patients also diagnosed with
fibromyalgia
or with a
psychiatric disorder
. No association was found between sleep disorders and the degree of functional status impairment. The mean REM latency and the percentage of subjects with a shortened REM latency were similar in CFS and HC.
...
PMID:Sleep anomalies in the chronic fatigue syndrome. A comorbidity study. 917 Jan 15
Fibromyalgia
is a common musculoskeletal pain disorder associated with mood disorders. Antidepressants, particularly tricyclics, are commonly recommended treatments. Randomized, controlled trials of antidepressants for treatment of
fibromyalgia
were reviewed by methodology, results, and potential predictors of response. Twenty-one controlled trials, 16 involving tricyclic agents, were identified; 9 of these 16 studies were suitable for meta-analysis. Effect sizes were calculated for measurements of physician and patient overall assessment, pain, stiffness, tenderness, fatigue, and sleep quality. Compared with placebo, tricyclic agents were associated with effect sizes that were substantially larger than zero for all measurements. The largest improvement was associated with measures of sleep quality; the most modest improvement was found in measures of stiffness and tenderness. Further studies are needed utilizing randomized, double-blind, placebo-controlled, parallel designs with antidepressants administered at therapeutic dose ranges, using standardized criteria for
fibromyalgia
and systematically assessed for co-occurring
psychiatric illness
.
...
PMID:Antidepressant treatment of fibromyalgia. A meta-analysis and review. 1074 47
The prevalence of chronic widespread pain in the general population in Israel was comparable with reports from the USA, UK, and Canada. Comorbidity with
fibromyalgia
(FM) resulted in somatic hyperalgesia in patients with irritable bowel syndrome. One sixth of the subjects with chronic widespread pain in the general population were also found to have a
mental disorder
. Mechanisms involved in referred pain, temporal summation, muscle hyperalgesia, and muscle pain at rest were attenuated by the N-methyl-D-aspartate (NMDA) antagonist, ketamine, in FM patients. Delayed corticotropin release, after interleukin-6 administration, in FM was shown to be consistent with a defect in hypothalamic corticotropin-releasing hormone neural function. The basal autonomic state of FM patients was characterized by increased sympathetic and decreased parasympathetic systems tones. The severity of functional impairment as assessed by the Medical Outcome Survey Short Form (SF-36) discriminated between patients with widespread pain alone and FM patients. Chronic fatigue syndrome (CFS) occurred in about 0.42% of a random community-based sample of 28,673 adults in Chicago, Illinois. A significant clinical overlap between CFS and FM was reported. Cytokine dysregulation was not found to be a singular or dominant factor in the pathogenesis of CFS. A favorable outcome of CFS in children was reported; two thirds recovered and resumed normal activities. No major therapeutic trials in FM and CFS were reported over the past year.
...
PMID:Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. 1122 36
Community studies have shown that stressful life events, psychological distress, and depressive and anxiety disorders are associated with 1) a range of medical symptoms without identified pathology, 2) increased health care utilization, and 3) increased costs. In both primary care and medical specialty samples, patients who have syndromes with ill-defined pathologic mechanisms (such as the irritable bowel syndrome and
fibromyalgia
) have been shown to have significantly higher rates of anxiety and depressive disorders than do patients with comparable, well-defined medical diseases and similar symptoms. Other studies show that after adjustment for severity of medical illness, patients with depression or anxiety and comorbid medical disease have significantly more medical symptoms without identified pathology than do patients with a similar medical disease alone. Both childhood maltreatment and psychological trauma in adulthood have been associated with increased vulnerability to
psychiatric illness
and more medical symptoms. The substantial functional impairment, distress, and costs associated with medical symptoms without identified pathology suggest that research studies promoting a better understanding of the biopsychosocial cause of these symptoms may yield pragmatic, cost-effective approaches to treatment in medical settings.
...
PMID:Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. 1134 29
The view that
fibromyalgia
syndrome (FMS) is a
psychiatric disorder
or can be caused by stress or abuse is unproven. The construct of posttraumatic FMS has not been adequately validated. Similarly, there is no evidence that communicating the diagnosis to patients causes iatrogenic consequences. Research suggesting a higher rate of posttraumatic stress disorder among those with FMS is weak. More research examining specific psychological processes in FMS is desirable. Because of the potential for harm to patients, clinicians should be cognizant of possible undue influences on medical opinion by agencies providing health care and research funding.
...
PMID:Psychosocial aspects of fibromyalgia. 1140 36
1
2
3
4
Next >>